David A. Siegel Bausch Health Companies Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 11,600 shares of BHC stock, worth $108,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,600
Previous 36,200
67.96%
Holding current value
$108,460
Previous $384,000
79.17%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding BHC
# of Institutions
266Shares Held
279MCall Options Held
5.68MPut Options Held
17.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$325 Million2.24% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$247 Million14.13% of portfolio
-
Goldentree Asset Management LP New York, NY22.4MShares$210 Million15.5% of portfolio
-
Nomura Holdings Inc Tokyo, M019.4MShares$181 Million0.27% of portfolio
-
National Bank Of Canada15.6MShares$146 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $3.38B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...